Neanderthal DNA may be making you a morning person: Study
New York, Dec 14 (IANS) Are you a morning person? Genetic material from our Neanderthal ancestors may have contributed to this propensity of rising early, according to a study.
New York, Dec 14 (IANS) Are you a morning person? Genetic material from our Neanderthal ancestors may have contributed to this propensity of rising early, according to a study.
New Delhi, Dec 14 (IANS) Cervical cancer death rates in low-to-middle-income countries can be reduced by more than 63 per cent through implementation of updated World Health Organization (WHO) screening guidelines, according to two studies.
New Delhi, Dec 14 (IANS) The market for cybersecurity in medical devices is expected to grow at a CAGR of 12.2 per cent by 2027 reaching $1.1 billion, according to a report on Thursday.
Canberra, Dec 14 (IANS) Mental health conditions have become the second-largest cause of illness and premature death in Australia, government data revealed on Thursday.
Lucknow, Dec 14 (IANS) Gaming addiction is leading to behavioural changes in children and also adults, according to experts.
New York, Dec 14 (IANS) Delivering the two-dose Mpox vaccine, called JYNNEOS, in smaller than the usual FDA-approved doses, produced a detectable immune response, regardless of whether people were living with or without HIV, according to a new study.
Tokyo, Dec 14 (IANS) Japanese researchers have developed models based on machine learning that predict the risk of visual impairment in patients with high myopia -- one of the top three causes of irreversible blindness in many regions of the world.
Washington, Dec 14 (IANS) The US Supreme Court said that it will consider whether to restrict nationwide access to a widely used abortion drug, even in the states where the procedure is still allowed after the landmark Roe v. Wade judgment was overturned last year.
Patna, Dec 13 (IANS) Six students at a government girls school in Bihar's Rohtas district fell sick on Wednesday, after the transfer of a teacher.
Hong Kong, Dec 13 (IANS) A team of researchers has developed an experimental new drug that has the potential to alter the gut microbiome and relieve multiple symptoms of long Covid.